Imbed Biosciences has raised a funding round of nearly $1.6 million, which the Fitchburg, WI-based startup plans to use to begin selling an ultra-thin wound dressing material later this year, CEO Ankit Agarwal says.
Imbed has been working to commercialize the dressing, which is known as Microlyte Ag, for years. It’s underpinned by nanofilm technology that uses silver’s antimicrobial properties to kill infection-causing pathogens, helping wounds heal in a way that does not require treatment with potentially harmful levels of the metal.
On its website, Imbed claims that Microlyte Ag contains anywhere from a dozen to hundreds of times less… Read more »
UNDERWRITERS AND PARTNERS